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Abstract
The HLA (Human Leukocyte Antigens) genes are well-documented targets of balancing
selection, and variation at these loci is associated with many disease phenotypes. Variation
in expression levels also influences disease susceptibility and resistance, but little informa-
tion exists about the regulation and population-level patterns of expression. This results
from the difficulty in mapping short reads originated from these highly polymorphic loci, and
in accounting for the existence of several paralogues. We developed a computational pipe-
line to accurately estimate expression for HLA genes based on RNA-seq, improving both
locus-level and allele-level estimates. First, reads are aligned to all known HLA sequences
in order to infer HLA genotypes, then quantification of expression is carried out using a per-
sonalized index. We use simulations to show that expression estimates obtained in this way
are not biased due to divergence from the reference genome. We applied our pipeline to the
GEUVADIS dataset, and compared the quantifications to those obtained with reference
transcriptome. Although the personalized pipeline recovers more reads, we found that using
the reference transcriptome produces estimates similar to the personalized pipeline (r�
0.87) with the exception of HLA-DQA1. We describe the impact of the HLA-personalized
approach on downstream analyses for nine classical HLA loci (HLA-A, HLA-C, HLA-B, HLA-
DRA, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1, HLA-DPB1). Although the influence
of the HLA-personalized approach is modest for eQTL mapping, the p-values and the cau-
sality of the eQTLs obtained are better than when the reference transcriptome is used. We
investigate how the eQTLs we identified explain variation in expression among lineages of
HLA alleles. Finally, we discuss possible causes underlying differences between expression
estimates obtained using RNA-seq, antibody-based approaches and qPCR.
Author summary
The level at which a gene is expressed can have important influence on the phenotype of
an organism, including its predisposition to develop diseases. One way to estimate gene
expression is by quantifying the abundance of RNA. RNA-seq has become the method of
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choice to provide such estimates at the genomewide scale. However, the application of
RNA-seq to HLA genes —key players in the immune adaptive response— has remained a
rarely explored approach. This is due to the problem of mapping bias, which causes defi-
cient read alignment at genes which are very polymorphic and different from the refer-
ence genome. This has motivated approaches that replace the single reference genome
with personalized sequences, comprised of the individual’s specific HLA genotype. Here
we explore the use of computational frameworks to obtain reliable expression levels for
HLA genes from RNA-seq datasets. We present a pipeline in which the quantification of
HLA expression is carried out using methods which account for HLA diversity, avoiding
the biases of standard approaches. We then evaluate the impact of this form of quantifying
HLA expression on downstream analyses. The pipeline also allows us to integrate infor-
mation on eQTLs with expression levels at the HLA allele-level, which can help disentan-
gle different contributions to disease phenotypes and help understand the regulatory
architecture at the HLA region.
Introduction
The HLA region is the most polymorphic in the genome, and also shows the greatest number
of disease associations, which has made it very well characterized at the genomic, population
and functional levels [1, 2]. Decades of research have also shown that the HLA genes are targets
of natural selection, likely a consequence of their role in responding to pathogens [2, 3]. This
combination of evolutionary and biomedical interest has resulted in an extensive catalogue of
HLA variation in human populations, with the frequency of HLA alleles defined for various
populations [4–7].
The most intensely studied genes in the region are the classical HLA loci. These include
Class I genes (HLA-A, HLA-C, and HLA-B), whose proteins present endogenous antigens to
CD8+ T cells, and also regulate innate immune responses by interacting with killer cell immu-
noglobulin-like receptors (KIR) expressed on natural killer (NK) cells, and Class II genes
(HLA-DRA, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1) whose pro-
teins present exogenous antigens to CD4+ T cells [1, 8].
Variation within or near HLA genes has been convincingly linked to resistance and suscep-
tibility to both autoimmune and infectious diseases [2, 9, 10]. Although in many cases the
mechanistic basis of the associations remains poorly understood, there has been an effort to
identify whether associations can be linked to features such as variation at the level of specific
amino-acids, HLA alleles, HLA haplotypes, non-coding variants near HLA genes, or HLA
expression levels (reviewed in [2, 10, 11]). In some instances, the association of one feature
results from the fact that it tags another feature. Several studies have shown that HLA alleles
may have a protective effect because they mark overall gene expression [12–15]. Other studies
showed that a combination of two features may be important. For example, mortality of trans-
plant recipients was associated with increased expression of HLA-C alleles which harbor spe-
cific amino-acids [16].
An understanding of how HLA expression varies among individuals, and the identification
of genetic variants involved in the regulation of expression, will play a central role in under-
standing the contribution of HLA genes to normal and disease phenotypes. However, until
recently, little information existed about the regulatory variation and population-level expres-
sion patterns of HLA genes, a result of the difficulty in quantifying expression for genes which
show an unusually high polymorphism and are members of a multi-gene family [9, 17].
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Efforts have been made to develop antibody-based methods to quantify HLA protein on
the cell surface [12–14, 18–20], or hybridization-based approaches to quantify mRNA, such as
qPCR [13, 21, 22] and microarray methods [23]. However, the design of PCR primers, micro-
array probes, or antibodies that span the diversity of possible variants represents a technically
challenging and labor-intensive undertaking. In addition, qPCR technologies are not appro-
priate for comparison of expression levels among different loci, an important concern when
seeking to understand how expression of HLA genes responds to environmental challenges.
The results obtained to date using qPCR [13, 21, 22], antibody-based approaches [12–14,
18–20] and customized arrays [23] have contributed to the understanding of HLA expression
and its underlying genetic regulation. However, they do not take advantage of the large
amount of RNA-seq data generated by studies of whole transcriptomes in large samples [24–
26], often involving populations from various regions of the world, which represents an attrac-
tive resource to investigate HLA expression.
Although such whole-transcriptome RNA-seq studies do provide expression estimates for
HLA genes, they bring new challenges. RNA-seq pipelines may provide biased expression esti-
mates for two reasons: 1) many short reads originating from genes with extreme polymor-
phism fail to map to the reference genome, due to high degree of variation (which results in a
large number of mismatches between the reference genome and that of most individuals being
analyzed), and 2) the presence of paralogues makes it difficult to map a read uniquely to a spe-
cific gene, leading to the exclusion of many reads. This raises concerns about the reliability of
RNA-seq approaches to quantify HLA expression, given that these loci represent both the
extreme of polymorphism in the human genome and are part of a multi-gene family [27–29].
A strategy to overcome these challenges is the mapping of reads to an HLA-personalized
reference (an index containing sequences of the individual being quantified), rather than to a
single reference genome. For example, seq2HLA is a tool developed by Boegel et al. [30] to
provide in-silico HLA types and expression estimates, and later applied to demonstrate that
different tumor types are associated with different HLA expression levels [31], and also to pro-
vide a large catalog of HLA expression in 56 human tissues and cell types [32]. AltHapA-
lignR [33] is another software which infers the HLA references which are the closest to the
individual’s HLA haplotypes, and maps reads to them. The authors reanalyzed a large RNA-
seq dataset [24], and provided comparisons with conventional read mapping, showing an
improvement in accuracy with the HLA-tailored pipeline.
In this article we present HLApers, a personalized pipeline which we have developed to
reliably quantify HLA expression from RNA-seq data. We compare HLApers to conventional
pipelines, and discuss for the first time the impact of accurate estimation of HLA expression
on downstream analyses such as eQTL (expression Quantitative Trait Loci) mapping and
allele-specific expression. We show that it is possible to adapt different computationally effi-
cient methods to work under the personalized reference framework, providing reliable quanti-
fication of HLA expression from RNA-seq data. We find that implementations with either a
conventional read mapper [34] or a pseudoaligner [35] show similar expression estimates.
We use simulations to assess accuracy, showing that the HLA-personalized pipeline is more
accurate than conventional mapping, and apply the tool to reanalyze RNA-seq data from the
GEUVADIS Consortium [24], which made available whole-transcriptome RNA-seq data for
Lymphoblastoid Cell Lines (LCLs) from 462 European and African individuals. We evaluate
the impact of more accurate expression estimates obtained with HLApers on downstream
analyses by carrying out a detailed survey for allele-specific expression and eQTL mapping at
the classical HLA loci.
Surprisingly, we find that conventional RNA-seq pipelines provide gene-level expression
estimates and identify eQTLs which are highly correlated with those obtained under the HLA-
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personalized approach. However, we identify gains of using a pipeline tailored for HLA expres-
sion: higher accuracy, expression estimates at the HLA allele-level, and eQTLs with higher
probabilities of being causal.
Results
Estimating HLA expression with HLApers
We developed the HLApers pipeline (for HLA expression with personalized genotypes) to
measure HLA expression from whole-transcriptome RNA-seq data. The pipeline can use
either (1) a suffix array-based read mapper (STAR [34]) followed by quantification with
Salmon [36] (henceforth called STAR-Salmon), or (2) a pseudoaligner with built-in quantifica-
tion protocol (kallisto [35]). The key feature of our implementation is the use of an index
supplemented with a set of sequences covering the breadth of known HLA sequences (see
Materials and methods: Index supplemented with the HLA diversity). We implemented a two-
step quantification approach, where (1) we align reads to reference sequences corresponding
to all known HLA alleles, and identify those which maximize the read counts at each locus to
infer the genotype which is present (in-silico genotyping), and (2) we use this inferred HLA
genotype to create a personalized index which we use to quantify expression (Fig 1).
A problem for the analysis of HLA is that of multimaps: reads originating from a particular
allele which map to other alleles of the same locus, or to other loci. To deal with multimaps dif-
ferent approaches have been used. One possibility is to discard them (as in [33]), and another
is to split them evenly among the compatible references (as in [30]). In HLApers, we use maxi-
mum likelihood estimates of expression obtained by an expectation-maximization (EM) algo-
rithm (implemented within Salmon [36] and kallisto [35]), which infers the quantities of each
HLA allele that maximize the probability of observing the set of sequenced reads.
Because the in-silico typing is an important step for accurate expression estimates, we
assessed the concordance between our RNA-seq based HLA typing and the HLA allele calls
experimentally determined for 5 HLA loci using Sanger sequencing [6]. The concordance was
higher than 97% for all of the HLA genes compared (S1 Table). This is consistent with previous
results showing that RNA-seq provides reliable HLA alleles calls [30, 37–40].
Fig 1. Schematic representation of the HLApers pipeline to estimate HLA expression. The reads generated by
RNA-seq are represented by curved shapes. The pipeline can use as input either reads in fastq format or extracted from
a BAM file (Input data). These reads are aligned to an index containing references for all known HLA alleles
(Alignment 1). We next identify the references to which most reads align, so as to infer the HLA genotypes of the
individual at that locus, in this example a heterozygote carrying a blue and a red allele (HLA typing). Next, a second
alignment is performed, using as an index only the references for the alleles inferred to be present in that individual at
that locus (Alignment 2). Expression is estimated based on the number of reads aligning to each reference, using a
statistical model that accounts for instances where reads align to multiple HLA references corresponding to different
HLA alleles or genes (Quantification). For each HLA allele, the quantification corresponds to the proportion of the
total reads assigned by the statistical model.
https://doi.org/10.1371/journal.pgen.1008091.g001
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Our HLApers pipeline integrates widely used quantification tools such as Salmon and kal-
listo, and provides both allele and locus level estimates of HLA expression. The pipeline is
available at https://github.com/genevol-usp/HLApers.
HLApers performance on simulated data
We next investigated how using the HLA-personalized index affects the quantifications of
HLA expression. To this end we simulated an RNA-seq experiment using the Polyester pack-
age [41], with a dataset of 50 individuals, with the read length and counts matching those of
the observed data (see Materials and methods: Simulation).
We analyzed the simulated dataset with three different methodologies: (1) the two-step
approach in HLApers, where we first inferred the personalized HLA genotype and then
aligned reads to it; (2) alignment to the reference transcriptome (Gencode release 25; primary
assembly); and (3) alignment to the reference genome (GRCh38). In approaches (1) and (2)
the alignment is followed by expression quantification using Maximum Likelihood (ML),
which provides a statistical framework for dealing with multimap reads, whereas in approach
(3) quantification is performed using only uniquely mapped reads.
For each HLA locus and methodology, we assessed the proportion of simulated reads
which successfully aligned. Because previous studies for genome sequencing identified a corre-
lation between mapping success and the number of mismatches between the HLA allele an
individual carries and the reference genome [28], we analyzed how alignment success behaves
as a function of the number of mismatches between each HLA allele and the reference genome
(Fig 2).
The use of an HLA-personalized index results in the largest proportion of successfully
aligned reads, no matter how different the allele carried by the individual is from the allele in
Fig 2. Alignment success with three different methodologies. The proportion of simulated reads which successfully
aligned is defined for each locus by the ratio of the estimated read counts to the number of simulated reads (y-axis).
These values are displayed as a function of the divergence of the HLA allele to the reference genome (x-axis). Simulated
reads were processed through 3 different pipelines: (1) alignment to the personalized HLA sequences (HLApers (ML)),
(2) alignment to the reference transcriptome (Ref Transcriptome (ML)), (3) alignment to the reference genome
considering only uniquely mapped reads (Ref Genome (Unique)).
https://doi.org/10.1371/journal.pgen.1008091.g002
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the reference genome. This is expected, since the personalized HLA component guarantees
that a sequence close or identical to that originating the read will be present.
When the alignment was performed using the reference transcriptome, there was a
marked reduction in the proportion of successfully aligned reads for HLA-DRB1, HLA-DQA1,
HLA-DQB1, driven by decreased alignment success for alleles with a greater proportion of
mismatches with respect to the reference genome.
When using uniquely mapped reads there was a massive read loss for HLA-A, HLA-B and
HLA-DPB1, regardless of the divergence to the reference genome, as well as a lower proportion
of successfully aligned reads across other loci. This shows that both discarding multipmaps, as
well as not including a personalized index, have a negative impact on mapping success.
Finally, for the least polymorphic HLA loci, mapping should not be sensitive to the specific
reference used. This is precisely what we find, with all pipelines performing similarly for HLA-
DRA and HLA-DPA1.
HLApers analysis of the GEUVADIS dataset
Having demonstrated that including an individual’s HLA alleles in the index improves the suc-
cess of read alignment in the simulated data (Fig 2), we set out to address two questions with
real data by applying HLApers to the GEUVADIS dataset [24]. First, we examined how expres-
sion varies among HLA loci, when the personalized index is used (Fig 3). Secondly, we com-
pared expression estimates with and without the use of the personalized index, so as to
evaluate the impact of its usage on real data (Fig 4).
By summing the estimates for the 2 alleles at each HLA locus, we obtain gene-level expres-
sion estimates (Fig 3). We observe that HLA-B is the highest expressed gene overall. Among
the Class I genes, HLA-B is followed by HLA-A with similar levels, and by HLA-C which
has about 50% of the expression levels of HLA-B. For Class II genes, HLA-DRA is the most
highly expressed. Although we observe a general concordance with the original GEUVADIS
Fig 3. Gene-level expression of classical HLA genes in 358 European individuals from GEUVADIS [24].
Expression was estimated with the HLApers pipeline. Horizontal lines inside each box represent the median. The
lower and upper hinges correspond to the first and third quartiles respectively. The whisker lines extend from the
hinges to the largest value no further than ±1.5 × IQR from the hinge (where IQR is the inter-quartile range, or
distance between the first and third quartiles). Data beyond the end of the whiskers (“outliers”) are plotted
individually. TPM: Transcripts per Million.
https://doi.org/10.1371/journal.pgen.1008091.g003
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quantifications [24], there are some notable differences: in the original quantifications, HLA-B
is twice as expressed as HLA-A, and HLA-DPA1 is more expressed than HLA-DRB1 (S1 Fig).
We found that the correlation between results using the reference transcriptome or the per-
sonalized index was greater than 0.87 for every locus except for HLA-DQA1 (Fig 4). The loci
with the lowest correlations between indices (HLA-DRB1, HLA-DQA1 and HLA-DQB1), are
also those with the greatest read loss when divergence from the reference allele is high in the
simulation (Fig 2).
We then investigated if the quantification tool used in HLApers (STAR-Salmon or kallisto)
influences expression estimates. Correlations between STAR-Salmon and kallisto approaches
were on average r> 0.99 for read counts, dropping to r = 0.8 for TPM estimates for Class I
genes, likely due to different bias correction models (S2 Fig). These results show that the key
features influencing alignment success are the use of a personalized index and the statistical
treatment of multimaps (as opposed to discarding them), with the specific alignment tool
being less influential.
Finally, we evaluated the reproducibility of the HLA expression estimates obtained with
HLApers. To this end, we analyzed replicates for 97 European individuals in GEUVADIS. We
observed an average correlation of expression estimates between replicates of 0.92 over the 9
classical HLA loci. This shows that HLA quantifications from RNA-seq with HLApers are
highly reproducible (S3 Fig).
eQTL analysis of HLA loci
The key role played by HLA loci in the immune response and their strong and abundant asso-
ciations with infectious and autoimmune diseases have motivated studies to uncover their reg-
ulatory architecture [15, 20, 21, 23, 42–45].
Fig 4. Expression estimates using personalized HLA genotypes (x-axis) versus the reference transcriptome (y-axis)
in the index. For each individual we identify the average divergence (proportion of mismatches) with respect to the
reference genome, indicated by the red gradient. For all loci with low correlations between expression quantification
methods, there is a marked drop in expression estimates using the reference transcriptome when the alleles are most
divergent from the reference. Expression estimates are in Transcripts per Million (TPM). r: Pearson correlation
coefficient.
https://doi.org/10.1371/journal.pgen.1008091.g004
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Here we use accurate expression estimates obtained with HLApers, together with genotype
data from the 1000 Genomes Project [46], to identify SNPs which are associated with variation
in expression levels (eQTLs).
Because multiple SNPs can affect expression, it is interesting to identify independent contri-
butions made by distinct SNPs. This has previously been done by using a best eQTL (i.e., the
one with the most extreme p-value) as a covariate in subsequent searches for an additional var-
iant. Here we use a related approach implemented in QTLtools, a collection of tools to per-
form eQTL analysis [47]. The module QTLtools cis allows for the identification of groups
(or “ranks”) of SNPs associated with independent signals. For each rank, we identified the site
with the most extreme association (Fig 5).
eQTL differences across indices. Although expression estimates obtained using HLApers
or reference transcriptome are significantly correlated, for some loci bias affects estimates
from the reference transcriptome for HLA alleles which are highly diverged from the reference
(Figs 2 and 4). We therefore examined if these differences in expression across indices have a
direct effect on the eQTLs identified.
Even when eQTLs across studies or pipelines are different, they may tag the same biological
signal (possibly driven by the same causal site). A high level of linkage disequilibrium (LD)
between two SNPs is not enough to claim shared biological signal, since the LD structure in
the genome may produce coincidental overlaps of variants which are unrelated in respect to a
given regulatory function [48]. However, if two SNPs tag the same signal, we expect to see a
decrease in the strength of association of one SNP when removing the effect of the second
SNP. This is the logic underlying the Regulatory Trait Concordance (RTC) method [47, 48],
which we use to test if eQTLs from different pipelines mark the same signal. An RTC score
close to 1 indicates that a pair of SNPs likely capture the same biological signal.
We found that the lead eQTLs capture the same biological signals across indices for all loci
except HLA-DRB1 (S2 Table). Despite this sharing of eQTL discoveries, the p-values for the
eQTLs mapped under the HLA-personalized pipeline are almost always more extreme than
those from the reference transcriptome (Fig 5).
eQTL sharing with previous studies. Next we investigated whether the eQTLs which we
mapped share the same causal signal as those reported by previous studies. We first queried
selected publications which focused on expression of genes with immune function, and that
described SNPs with a functional role on HLA expression (in some cases with experimental
validation) [12, 13, 42, 45, 49–51].
We found that our eQTLs for HLA-C are very highly correlated at the haplotypic level (0.95
�D0 � 1) with the variants described by Thomas et al. [12] (a -35bp SNP in HLA-C promoter),
Kulkarni et al. [42] (a SNP which regulates HLA-C expression via a 3’UTR miRNA binding
site), Fairfax et al. [49] (a genome-wide significant eQTL in PBMC (Peripheral Blood Mono-
nuclear Cells)), and Vince et al. [50] (a SNP in the Oct1 binding site in the HLA-C promoter
region). A similar pattern holds for the rank 1 eQTL which we mapped for HLA-DQB1, which
is in high LD (D0 = 1) with a variant reported by Raj et al. [45] within a super-enhancer which
regulates HLA-DQA1, HLA-DQB1 and HLA-DRB1. For HLA-DP we also found strong associ-
ation (D0 = 1) between our eQTLs and previous SNPs with regulatory role for HLA-DPB1 [13]
and HLA-DPA1 [51] (S3 Table).
However, as we discussed above, the RTC method is more appropriate than linkage disequi-
librium (LD) to evaluate the sharing of causal signals. When applied to these SNPs which are
in high LD with our eQTLs, we find that only the association between our HLA-C rank 1
eQTL and previously identified regulatory SNPs was significant according to the RTC crite-
rion, showing a high probability (RTC = 0.99) that our eQTL shares the same biological
signal with the SNP of Fairfax et al. [49]. We next expanded our RTC analysis to a catalog of
Expression estimation and eQTL mapping for HLA genes
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Fig 5. eQTLs for HLA loci. A: Distribution of p-values for the association between genotypic and expression variation
along the HLA region, colored by gene. B: Distribution of p-values around the transcription start site (TSS, vertical line
at x = 0), for eQTLs mapped with HLApers or reference transcriptome pipelines. Points are colored according to the
rank of association (with gray for non-significant associations at an FDR of 5%). The best eQTL of each rank is circled
in black. Green arrows indicate the orientation of transcription. There was no eQTL mapped for HLA-DRA.
https://doi.org/10.1371/journal.pgen.1008091.g005
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previously described SNPs, including large eQTL studies of LCLs [24, 26, 52]. We find that,
overall, 9 of the 17 eQTLs we identified likely share the same causal signal as previous eQTLs
or experimentally validated SNPs (S3 Table).
Remarkably, only 1 of the 6 eQTLs mapped for HLA-DQA1, HLA-DQB1, and HLA-DRB1
share a signal with previous eQTLs. This is consistent with our finding that for these genes
the expression estimates are affected by divergence from the reference genome (Figs 2 and 4),
which may have led to incorrect estimation of expression in previous studies.
Putative function of eQTLs. To gain insight into possible function of the eQTLs mapped
with HLApers, we examined their location with respect to the associated HLA gene and func-
tional annotation for LCLs in The Encyclopedia of DNA Elements (ENCODE [53]) (S4 Table).
Considering all ranks of association, we mapped 17 eQTLs for a total of 8 classical HLA
genes. HLA-DRA is the least polymorphic classical gene, and had no associated eQTL. The
lead eQTL was located no further than 20kb from the gene for all classical HLA genes except
HLA-DQA1, for which the lead eQTL was 82kb upstream the transcription start site (TSS), but
within a cloud of associations which extends to the TSS, and for HLA-B where the lead eQTL
was 210kb away, an unusually large distance with respect to that of the other loci, but still
within a range found in the genomewide eQTL data (where 11.1% of the eQTLs lie at that dis-
tance or further).
Six of the 17 eQTLs are part of TFBS (Transcription Factor Binding Sites) or DHS (Dnase I
Hypersensivity Sites). Regarding chromatin modification, 10 eQTLs were located within
regions with marks of active promoters, enhancers or other distal elements, transcribed genes,
or elements with dynamic chromatin (S4 Table).
We also used RTC to evaluate if eQTLs identified in our study capture the same signals as
CRD-QTLs identified by Delaneau et al. [52]. CRDs (for Cis-Regulatory Domains) are seg-
ments of the genome defined by chromatin activity and formed by coordination between
nearby regulatory elements [52] (see S4 Fig for the location of HLA genes with respect to
CRDs in the region). A high RTC score between a CRD-QTL and an eQTL indicates a shared
influence on the formation of a CRD and on gene expression. Overall, 9 out of 17 eQTLs we
identified mark the same signal as CRD-QTLs. Interestingly, the lead eQTL for HLA-B, which
is 210kb away from the gene, has an RTC score of 0.99 with a variant associated with the activ-
ity of the CRD linked to HLA-B (S5 Table).
Studies have revealed a significant overlap of eQTLs and variants identified in GWAS
(Genome-Wide Association Studies), which provides insight into a biological basis for the
GWAS association [11, 24, 54–56]. Most GWAS variants are non-coding, and in those cases it
is difficult to know which variant is causal and which gene is modulated, complicating the
identification of the direct effects of variants on disease etiology [48, 57]. The mapping of
eQTLs, by identifying variants involved in modulating expression, offers an additional layer of
information for interpreting GWAS hits. Thus, we sought to investigate the overlap between
eQTLs we mapped and GWAS signals.
We found that nearly all of our eQTLs, according to the RTC score, likely share the same
biological signal as GWAS hits (S6 Table), which shows an extensive implication of regulation
of gene expression in disease phenotypes at the HLA region. However, the high density of
GWAS hits in the HLA region, coupled with a high linkage disequilibrium, provides an alter-
native explanation for this pattern.
Causality. A key challenge for eQTL studies is identifying which variants are causally
related to variation in expression, and which are simply genetically correlated with the func-
tional variant. One approach to identify causal variants is to use empirical and simulated data
on eQTLs in a probabilistic framework, to estimate the probability that a variant is causal. We
used this approach, as implemented in CaVEMaN software [55], to estimate the probability
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that the eQTLs we mapped are causal, and to evaluate if more accurate expression estimates
could lead to improved mapping of causal variants.
For 10 out of 14 eQTLs (excluding HLA-DP, for which eQTLs are the same across pipe-
lines), we found that the HLApers produces eQTLs with higher probabilities than the reference
pipeline. However, most variants do not reach probabilities of 0.8, indicating that even though
there is an increase in probability of causality when using HLApers, larger samples sizes are
important to improve fine mapping (S5 Fig).
HLA allele-level analysis
Transcriptome studies can quantify expression for various biological features: individual
SNPs, exons, isoforms, genes. In the case of HLA loci, a natural unit of interest is the HLA
allele. HLApers provides expression estimates for individual alleles, since it is the allelic
sequences which are included in the index. The immunogenetics literature has shown that
many HLA alleles are associated with specific phenotypes of evolutionary and medical impor-
tance (reviewed in [2, 10, 11]). Gauging information about the expression levels of alleles can
therefore provide an additional layer of information.
In order to explore allele-level estimates, we first grouped alleles in “lineages”, which com-
prise groups of alleles which are evolutionarily and functionally related, since the large number
of alleles would make sample sizes per allele too sparse. Although the expression of individual
allelic lineages is highly variable among individuals, there is an overall significant difference in
expression among lineages (Welch’s ANOVA p-values ranging from 3.7 × 10−8 for HLA-DPB1
to 6 × 10−51 for HLA-DQA1).
Concordance with previous allele-level estimates. We then compared our allele-level
expression with those previously obtained for HLA-A, HLA-B and HLA-C by qPCR [21, 22,
43]. For each locus, we restricted our analyses to lineages in at least 10 individuals, and with
significantly different expression from at least one other lineage (Mann-Whitney U test with
FDR correction for multiple testing, p< 0.05). We found 33 instances where the expression
was significantly different between a pair of lineages in both qPCR and RNA-seq datasets, and
in 21/33 cases the results were concordant (i.e., we found the same ordering of expression in
RNA-seq and qPCR). However, the results were markedly different among loci: for HLA-C, 13
out of 13 significant pairs were concordant, for HLA-B, 4 out 6 were concordant. On the other
hand, for HLA-A, qPCR and RNA-seq results were concordant in only 4 out 14 pairs (see S1
Text for details). Future scrutiny will be needed to determine whether qPCR and RNA-seq
have biases specific to HLA-A, or if these differences can be explained by biological factors
such as different populations/samples and tissues/cell types.
HLA allele lineages and eQTLs. To investigate HLA regulation at the allele-level, we esti-
mated expression levels for HLA alleles, and we inferred haplotypes that spanned HLA loci
and eQTLs, so that the phasing between these was known (see Materials and methods: Phasing
of HLA alleles).
We investigated the degree to which the mapped eQTLs account for variation in expression
levels of HLA alleles. Frequently, we observe that more highly expressed HLA alleles are on
haplotypes carrying the eQTL allele associated with increased gene-level expression (red dots
in Fig 6). At HLA-C, for example, the rs41561715-T allele is exclusively associated with the
C�04 lineage. Another eQTL completely linked to HLA lineages is seen at HLA-DPB1. The
alleles at this locus were previously divided into two clades, marked by the variant rs9277534
in the 3’-UTR [13, 58, 59]. The alleles DPB1�02, DPB1�04 and DPB1�17 are on the same haplo-
type as rs9277534-A, and have low expression. The other alleles are on haplotypes carrying
rs9277534-G, and have higher expression [13, 58, 59], which may increase the risk of persistent
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Fig 6. Expression levels for different HLA lineages and eQTL genotypes. For each locus panel we have: (left-hand
side) expression estimates for each HLA allele in Transcripts per Million (TPM), and (right-hand side) gene-level
estimates for each eQTL genotype in PCA-normalized estimates used for eQTL mapping. Allelic lineages with� 10
individuals are shown.
https://doi.org/10.1371/journal.pgen.1008091.g006
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Hepatitis B virus (HBV) infection [13]. Here we mapped rs9277449 as the lead eQTL for
HLA-DPB1. We found that rs9277449 and rs9277534 are non-independent (2kb apart, D0 = 1,
both contained among the rank 0 variants (blue) in Fig 5), and rs9277449 also separates the
two clades of alleles based on expression (Fig 6).
These results show that reliable eQTL mapping may help explain differences in expression
among HLA alleles, and help identify genetic variants which contribute to disease risk.
Allelic imbalance. There is increasing interest in understanding if gene expression is
unbalanced (i.e., one allele is more expressed than the other), and if so, how this contributes to
interpretations of disease phenotypes and natural selection [60]. In the case of HLA genes, for
which heterozygote advantage is a selective regime with strong theoretical support, extremely
unbalanced expression poses a theoretical challenge, since being heterozyote would not be
advantageous if only one allele is expressed. We have used our expression estimates to quantify
allelic imbalance for HLA genes.
Using the expression data at the HLA allele-level we found low asymmetry in expression
(Fig 7), with 81% of the heterozygotes having ASE (Allele-Specific Expression) between 0.4
and 0.5 (with Class II genes showing a distribution with a larger variance), and no instances of
extreme imbalance as recently reported for SNPs in HLA genes [61]. Therefore, the extreme
imbalance seen at the SNP level does not hold at the HLA allele resolution.
Co-expression and haplotypic coordination in expression
Enhanced coordination of gene expression has been proposed as an advantage for gene clus-
tering, as seen at the HLA region [1, 2]. We found a high correlation of expression both within
the group of Class I and Class II genes, and lower levels between Class I and Class II genes,
which are more than 1Mb apart (Fig 8A) (but see [22] for a result of no co-expression among
Class I genes).
A possible cause for co-expression of genes which are physically close to each other is that
regulatory activity is structured in domains (CRDs, for Cis Regulatory Domains) [52]. Such
domains comprise contiguous regions along a chromosome, and their existence predicts co-
expression along haplotypes for genes associated with the same CRD. In fact, previous studies
did find evidence that expression of some genes in the HLA region was a feature associated
with haplotype membership [23, 62].
We used our inferences of HLA haplotype structure to investigate if there is an haplotypic
effect on coordination of expression among nearby HLA genes. Specifically, we tested the
Fig 7. Allele-specific expression. ASE was measured as the proportion of the locus-level expression attributed to the
less expressed HLA allele in heterozygous genotypes. Red horizontal bars indicate the median.
https://doi.org/10.1371/journal.pgen.1008091.g007
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hypothesis that co-expression is stronger between alleles located within the same haplotype
than between those on different haplotypes. We did not find a consistently higher correlation
of expression for alleles on the same haplotype (correlation within haplotypes being higher in
only 7 out of 18 locus pairs surveyed within Class I or Class II, Fig 8A).
This result suggests that correlation of expression among HLA loci in LCLs is a result of fac-
tors acting at the gene level, and is not driven predominantly by properties of the haplotype.
For example, we observe correlation of expression between Class II genes and CIITA, the Class
II Major Histocompatibility Complex Transactivator. This correlation is not driven by prox-
imity (CIITA is on chromosome 16), but rather by a trans regulatory mechanism (Fig 8B).
Discussion
The contribution of HLA variation to normal and disease phenotypes goes beyond peptide
specificity, and includes other factors which influence the strength of immune responses, such
as HLA expression levels. However, we are still only starting to understand the regulation of
expression of these genes, a consequence of their extreme polymorphism which imposes chal-
lenges to the methodologies available to measure mRNA and protein levels.
There has been an increasing effort to use RNA-seq data for in-silico HLA typing ([63] and
other methods reviewed in [64]) and to estimate expression levels for HLA genes [30, 33]. In
this paper, we present HLApers, an HLA-personalized pipeline that quantifies HLA expression
based on RNA-seq. We used these expression estimates to identify eQTLs for HLA genes, to
estimate the degree of allelic imbalance in expression, and to investigate how the alleles at
eQTLs explain variation in expression among HLA alleles.
When new technologies/methods are developed, it is a good practice to evaluate if the results
are in agreement with the current knowledge, which in the case of HLA was mostly derived
Fig 8. Co-expression patterns for HLA genes. A: Pairwise correlation of expression estimates at the gene-level, for
alleles from within the same haplotype, and for alleles on different haplotypes. B: An example of a factor that
contributes to correlation of expression at the gene level. CIITA is located on chromosome 16, and its protein regulates
the expression of Class II genes. r: Pearson correlation coefficient.
https://doi.org/10.1371/journal.pgen.1008091.g008
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from qPCR or antibody-based studies. However, in our survey of this literature, we found it dif-
ficult to compare our newly obtained expression estimates based on RNA-seq with those from
previous studies. There are several reasons underlying this difficulty, which we now discuss.
First, expression estimates based on qPCR and antibody-based approaches are in general
not comparable among different HLA loci, since different primers/antibodies are often devel-
oped for each locus. Thus, the information for expression differences which we observe among
HLA loci are usually not available from studies using these techniques. A few studies developed
antibodies with comparable affinities for HLA-A/B/C, allowing comparison of expression
between loci. Using such a method, Apps et al. [19] found an at least 12-fold reduction in
HLA-C expression with respect to HLA-A and HLA-B as measured by flow cytometry,
whereas the difference we documented based on RNA-seq was only twofold. However, the
Apps et al. [19] study was restricted to a specific haplotype, and because our results show sub-
stantial within locus variation in expression levels, it is difficult to compare studies.
Second, many additional layers of biological factors make a direct comparison across stud-
ies challenging. For example, the abundance of total protein, of proteins on cell surface or of
mRNA in the cell, represent different molecular phenotypes associated with gene expression,
given the existence of various post-transcriptional and post-translational regulatory processes
[18, 20, 42, 43, 65, 66]. As a consequence, there are good biological reasons to expect differ-
ences when expression is estimated at each of these levels. In addition, it is well known that
gene expression varies among tissues and cell types [26, 32], posing an additional challenge in
comparisons between our findings and those previously reported in the literature, which are
often based on analyses of different cell types or tissues.
Third, regarding mRNA quantification, qPCR and RNA-seq each have their own sources of
bias, and the finding that there are differences between studies using these approaches should
not, on its own, provide definitive evidence that one or the other is inaccurate. Future studies
will need to evaluate the degree to which these two technologies can be compared for quantifi-
cation of HLA expression.
Nevertheless, given the availability of qPCR based quantifications for HLA expression, as
well as the interest in obtaining allele-level estimates of expression, we compared the expres-
sion for individual HLA lineages obtained by RNA-seq with those from qPCR from previous
studies. We found that RNA-seq and qPCR show high concordance for the relative ordering of
lineage-level expression for HLA-B and HLA-C (66% and 100%, respectively), whereas for
HLA-A concordance was low, at 28%. Therefore results suggest that for HLA-B and HLA-C,
when we examine lineages that are sufficiently different in their expression relative to one
another (see S1 Text), the two methods are in high agreement, but further research is required
to identify the sources of discordance between RNA-seq and qPCR for HLA-A. It is important
to recall that these analyses rely on lineage-level expression estimates obtained by qPCR which
are indirect, since they estimate locus-level expression (whereas RNA-seq data analysis with
HLApers distinguishes among alleles), adding another source of differences among methods.
Our perspective is that differences across studies call for further investigation, and highlight
the potential biological variation that needs to be accounted for when comparing cell types,
infection status, methodological approach, and molecule being quantified.
In this study we present HLApers, and use simulations and empirical data analyses to show
that it produces estimates for HLA expression from RNA-seq with high precision and accu-
racy. HLApers incorporates a Maximum-Likelihood estimator to deal with instances of reads
mapping to multiple alleles or loci, following a strategy that has been widely used in RNA-seq
studies [26, 67]. Our pipeline can use different alignment strategies (e.g. STAR-Salmon [34,
36] or kallisto [35]), but we show that the accuracy of expression depends on the sequences
contained in the index, and is less dependent on the program used.
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The impact of using an HLA-personalized index on expression estimates varies markedly
among loci. We found that for HLA-DQA1 there are large differences between gene-level
expression estimates obtained using the reference transcriptome and those obtained using the
HLA-personalized index. However, this difference is quite low for Class I genes, and interme-
diate for Class II loci other than HLA-DQA1 (Figs 2 and 4). However, even for the Class I
genes, using the personalized index does result in changes in expression estimates with respect
to the reference transcriptome. Therefore, we asked whether these changes have an impact on
downstream analyses, such as eQTL mapping.
When we compare the eQTLs identified using either HLApers or the reference transcrip-
tome, 6 out of 8 loci had non-overlapping eQTLs. However, in most cases the same biological
signal was being captured (S2 Table), and the p-values (Fig 5) and the causality (S5 Fig) of the
eQTLs obtained with HLApers are only modestly better than when the reference transcrip-
tome is used. We show that most of the eQTLs we identified (14/17) share a signal with previ-
ously reported regulatory SNPs (either experimentally validated SNPs and eQTLs (S3 Table)
or CRD-QTLs (S5 Table)). This indicates that, despite of the improvement in expression esti-
mates that personalized pipelines can generate, larger sample sizes are necessary in order to
identify eQTLs with greater probability of being causal, and to identify novel eQTLs with
smaller effects. We note that the use of transformed cell lines (such as LCLs) may lead to
expression profiles specific to this environment, and as a consequence some of the regulatory
architecture underlying the expression of the HLA genes may not be shared with other tissues,
cell types or treatments.
The HLA-personalized approach provides expression estimates at the HLA allele level,
which is not a product of standard RNA-seq pipelines. We integrate allele-level information
with the eQTLs mapped for the genes, showing that the HLA allele is a relevant layer of infor-
mation to understand the regulation of gene expression, because in some instances the regula-
tory architecture is linked to specific HLA alleles. This joint mapping of regulatory variants
and assessment of expression of HLA alleles can illuminate the understanding of the HLA reg-
ulation, and contribute to disentangle specific contributions to disease phenotypes.
Materials and methods
Ethics statement
All data were obtained from third party sources and no additional ethical approval was
required.
Index supplemented with the HLA diversity
In order to create the index, we downloaded 16,187 nucleotide sequences for 22 HLA loci
(HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-DMA, HLA-DMB, HLA-DOA, HLA-
DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB2,
HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRB7, HLA-DRB8) from the International Immu-
nogenetics/HLA database (IMGT) (release 3.31.0 available at https://github.com/ANHIG/
IMGTHLA).
For many alleles, sequence data is not available for the entire coding region (e.g., only for
exons 2 and 3 for class I, and exon 2 for class II genes, which are called ARS exons). Because
the lack of sequences for much of the coding region would cause the exclusion of many reads,
including those mapping to the boundaries of the available exons, for each allele with partial
sequence we used the available sequence to find the closest allele which has the complete
sequence, and attributed the sequence from this allele. This is expected to introduce little bias
in either the genotyping step (because ARS exons are the most polymorphic and sufficient to
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distinguish specific alleles) or the expression estimation (because the non-ARS sequence
attributed is likely very similar to the real one).
For the final index file, we replaced the HLA transcripts in the reference transcriptome
(Gencode v25, primary assembly) with the HLA diversity described above. STAR’s module
genomeGenerate, Salmon’s index, and kallisto’s index compile an index from these
sequences.
In-silico HLA typing
In order to select the alleles to be used in the HLA-personalized index, we observed that a
simple procedure of selecting the 2 alleles with the largest number of estimated read counts
after applying a zygosity threshold is sufficient to produce calls with accuracy of� 95%.
However, in order to avoid false homozygotes and false heterozygotes, we implemented
additional steps.
First, we selected the top 5 alleles and applied an intra-lineage threshold of 0.25, meaning
that only alleles which had at least 25% of the total expression in their lineage were considered
for further steps. For each individual, we compiled an index containing only these (up to) 5
alleles and estimated their expression. We then determined if the individual was heterozygote
at the lineage level by applying a threshold of 0.15 on lineage expression levels. The lead allele
from each lineage was selected to compose the genotype. A zygosity threshold of 0.15 was
applied to decide whether the genotype was heterozygous at the allele-level. For each locus, the
reads mapped to the lead allele were removed, and another step of alignment and quantifica-
tion was performed in order to determine if the second allele was real, or just noise due to
extensive similarity to the lead allele. If the second allele had at least 1% of the locus read
counts, it was kept, otherwise the genotype was considered to be homozygous for the lead
allele.
The thresholds described above were chosen because they maximized the concordance with
the Sanger sequencing typings [6], while also minimizing the rate of false homozygotes and
heterozygotes.
Expression quantification
We implemented two versions of the HLApers pipeline: (1) one using STAR (v2.5.3a) [34] to
map reads followed by Salmon (v0.8.2) [36] to quantify the expression, and (2) using kallisto
(v0.43.1) [35], which performs pseudoalignment and quantification.
The quantification pipeline is structured in a two-stage process, first identifying the most
expressed allele(s) at each HLA locus in order to infer the genotype which is present, and next
quantifying expression for these inferred genotypes as well as for the rest of the transcriptome
(Fig 1).
Reads were aligned directly to the transcriptome. STAR alignments were passed to Salmon
for quantification (module quant under alignment mode), whereas kallisto directly produces
quantifications with the quantmodule.
In both the HLA typing step (for which the index contains all HLA sequences in the IMGT
database) and the quantification step (for which an HLA-personalized index is used), short
reads can map to more than one locus, or more commonly to multiple alleles of the same locus
(multimaps). The quantification methods we are using deal with multimaps by inferring maxi-
mum likelihood estimates optimized by an expectation-maximization algorithm to probabilis-
tically assign reads to each reference in the index, and also include models to account for
sequencing bias.
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For the mapping with STAR, we tuned parameters in order to avoid discarding multimaps
and to accommodate mismatches. For quantification, we used all bias correction options avail-
able (–seqBias and –gcBias in Salmon, and –bias in kallisto).
Simulation
Polyester is an R package designed to simulate RNA-seq datasets [41]. We used the function
simulate_experiment_countmat to simulate transcriptome data for 50 randomly
chosen GEUVADIS individuals. Simulations were based on the read lengths and counts in the
original data, with library sizes of 30 million reads, sampling without bias from a normal distri-
bution of read start sites (with average fragment length of 250bp and sd of 25bp, and error rate
of 0.005). The code for the generation of the simulated datasets is available at https://github.
com/genevol-usp/hlaexpression/tree/master/simulation/data.
We processed the simulated reads with STAR-Salmon to perform the quantifications using
different indices:
1. HLA-personalized index (HLApers): Reference transcriptome with the annotated tran-
scripts for HLA genes replaced with sequences from the personalized genotypes;
2. Reference transcriptome: Gencode v25 transcripts from the primary assembly of reference
genome;
3. Reference Genome (GRCh38), considering only uniquely mapped reads.
To investigate the relationship between quantifications and sequence divergence with respect
to the reference, we used the R function adist to calculate the proportion of mismatches
between the HLA alleles carried by the individuals and the alleles in the reference genome.
GEUVADIS reanalysis
We quantified HLA expression based on RNA-seq data for 358 European individuals, in sam-
ples of LCLs (Lymphoblastoid Cell Lines), made available by the GEUVADIS Consortium [24]
(we excluded samples from the original dataset which are not in the 1000 Genomes phase 3).
We performed expression quantification using the HLApers and reference transcriptome
pipelines.
We evaluated the reproducibility of the HLA quantifications by analyzing a subset of 97
individuals for which a replicate was available (https://github.com/genevol-usp/hlaexpression/
blob/master/geuvadis_reanalysis/replicates/data/write_sample_info.R).
For the eQTL analysis, we used only autosomal genes which are expressed in a large propor-
tion of samples, exploring the thresholds of TPM> 0 in at least 25%, 50%, or 75% of samples.
In order to correct the expression data for technical effects, we sequentially removed the effect
of the first 0 to 100 PCs and ran an eQTL analysis for each condition (S6 Fig). The configura-
tion of thresholds and number of PCs which maximized the eQTL discovery (at FDR = 5%)
was considered. This resulted in the use of genes expressed in� 50% of samples (19,613
genes), and 60 PCs.
The PCA analysis and data correction were performed with QTLtools v1.1 [47], using
the modules pca and correct respectively. For the genetic variant data, we used the
1000 Genomes Phase 3 biallelic variants, lifted to GRCh38 coordinates, after filtering for
MAF� 0.05 in the individuals included in this study (6,837,505 variants in total).
In order to control for population structure in the eQTL analysis, we ran a PCA on the vari-
ant genotype data and assessed the PCs which captured the structure. We used QTLtools
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pca requiring that variants should be at least 6kb apart. After visual inspection of the plots in
S7 Fig, PCs 1–3 were used as covariates in the eQTL analysis.
We used QTLtools cis to conduct the cis-eQTL analysis using the following model:
PCA-corrected and standard normal expression � SNPsþ covariatesðPCs for population stratificationÞ
The permutation pass was performed with 1000 permutations and a cis-window of 1Mb. P-
values were computed by beta approximation and significance was determined by running the
script runFDR_cis.R provided by QTLtools with FDR of 5%.
Multiple eQTLs with independent effects on a particular gene were mapped with a condi-
tional analysis based on step-wise linear regression (see Supplementary method 8 in [47]). The
method automatically learns the number of independent signals per gene and provides sets of
candidate eQTLs per signal.
Functional annotation of eQTLs
In order to investigate the putative function of the eQTLs we mapped, we investigated whether
these eQTLs were present in ENCODE [53] regulatory elements annotated for LCLs. We used
three types of functional annotations: open chromatin regions given by DNAse footprinting,
transcription factor binding sites (TFBS) assayed by ChIP-seq, and histone modifications.
Regulatory Trait Concordance (RTC) analysis
We performed an RTC [48] analysis as described in [47] to investigate whether our eQTLs
tagged the same causal variant as a GWAS variant or previously reported eQTL.
We downloaded the GWAS catalog data (v1.0.1) from https://www.ebi.ac.uk/gwas/api/
search/downloads/alternative and selected associations with p-value < 10−8. We obtained the
coordinates of recombination hotspots from http://jungle.unige.ch/QTLtools_examples/
hotspots_b37_hg19.bed.
We applied the RTC module implemented in QTLtools (QTLtools rtc), selecting the
HLA region only, using a D’ threshold of 0.5, and turning on the conditional flag (–condi-
tional) to test all independent eQTLs for a gene.
Following the recommendation of Delaneau et al. (see Supplementary Note 7 in [47]), we
considered that two SNPs tagged the same functional signal if the RTC score was >0.9.
Phasing of HLA alleles
To investigate whether there is a haplotypic coordination of expression at HLA, we used
phased HLA genotype data to verify if there was more correlation of expression between alleles
on the same haplotype than on different haplotypes (Fig 8). To also assess the phasing between
HLA alleles and the eQTLs (Fig 6), we included the eQTLs mapped for each HLA gene in the
phasing procedure, accounting for the fact that their phasing was already known from 1000
Genomes Project.
In order to be conservative in the phase estimation, we used only the haplotype calls which
were concordant between two approaches for phasing. First, we used PHASE [68] to determine
the haplotype of each allele in the genotype, providing HLA allele designations and phased
eQTL genotypes as input. Second, we checked the compatibility of the individual HLA geno-
types with the phased SNP haplotypes from 1000 Genomes. Given all possible haplotypes for
each individual at HLA-G*A*E*C*B*DRA*DRB1*DQA1*DQB1*DPA1*DPB1,
we checked which combination of 2 haplotypes minimized the number of differences to the
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1000 Genomes data to infer the haplotypes present in the individual. This resulted in 417 hap-
lotypes completely concordant between the two approaches.
Code availability
The HLApers pipeline is available at https://github.com/genevol-usp/HLApers. The entire
analysis, including simulations, index compilation, quantification of expression, eQTL map-
ping, etc is available at https://github.com/genevol-usp/hlaexpression.
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S1 Fig. Gene-level expression of 358 European individuals in the GEUVADIS dataset
obtained with the HLA-personalized approach (top panel) or those originally reported by
GEUVADIS (bottom). TPM: Transcripts Per Million. FPKM: Fragments Per Kilobase of tran-
script per Million mapped reads.
(TIFF)
S2 Fig. Estimated counts (top) and TPM estimates (bottom) from STAR-Salmon (align-
ment via suffix array) and kallisto (pseudoalignment).
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S3 Fig. Expression estimates for replicates of 97 European individuals in GEUVADIS
obtained with the HLApers pipeline. Quantification estimates are in TPM (Transcripts per
Million). r: Pearson correlation. ρ: Spearman correlation.
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S4 Fig. Location of HLA genes in cis-regulatory domains (CRD).
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S5 Fig. CaVEMaN causal probabilities. On the X axis we have the QTLtools rank of the
eQTLs, and on the Y axis the CaVEMaN causal probability.
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S6 Fig. The number of eGenes (a gene with a least 1 eQTL) according to the number of PCs
used for phenotype correction.
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S7 Fig. Principal components of variant genotypes for 358 European individuals in the
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S1 Table. Accuracy of the in-silico HLA genotyping approach.
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S2 Table. RTC analysis between the eQTLs mapped with the HLA-personalized or refer-
ence transcriptome pipelines. If two SNPs have an RTC score >0.9 we consider that they
share a causal signal.
(CSV)
S3 Table. RTC analysis between the eQTLs we mapped and previous eQTLs from studies
on LCLs or HLA-target studies. If two SNPs have an RTC score >0.9 we consider that they
share a causal signal.
(CSV)
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S4 Table. Functional annotation of eQTLs from the HLA-supplemented pipeline. (1) Gene,
(2) QTLtools rank, (3) rs ID, (4) distance from the gene, (5) presence in transcription factor
binding sites (TBFS), (6) DNase I hypersensitive sites (DHS), and (7) histone modifications
annotated for LCLs in ENCODE.
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S5 Table. RTC analysis between the eQTLs mapped with the HLA-personalized pipeline
and CRD-QTLs. If two SNPs have an RTC score >0.9 we consider that they share a causal
signal.
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pers and previous qPCR-based estimates.
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